Literature DB >> 35023055

Just the facts: testing patients with suspected pulmonary embolism.

Kerstin de Wit1,2,3, Oksana Motalo4, Shreyash Dalmia5.   

Abstract

Entities:  

Keywords:  Diagnosis; Pulmonary embolism

Mesh:

Substances:

Year:  2022        PMID: 35023055      PMCID: PMC8754359          DOI: 10.1007/s43678-021-00260-2

Source DB:  PubMed          Journal:  CJEM        ISSN: 1481-8035            Impact factor:   2.929


× No keyword cloud information.

Clinical scenario

A 60-year-old woman is brought to the emergency department by ambulance with a 1-day history of dyspnea, chest pain, and fever. She had myalgia and sore throat for 4 days prior. She denies hemoptysis and leg swelling. Her past medical history includes essential hypertension. She has no surgical history. There is no personal or family history of venous thromboembolic (VTE) disease. At triage, her temperature is 38 °C, heart rate of 120, blood pressure of 158/77, and oxygen saturation of 92% on room air. On examination, she is in mild respiratory distress with fine bibasilar crackles and normal heart sounds. Peripheral vascular exam is unremarkable. You are waiting for her COVID-19 test results. An electrocardiogram shows sinus tachycardia. Her chest X-ray is normal. She has positive Pulmonary Embolism Rule-out Criteria (PERC score) [1] based on her age, heart rate, and oxygen saturation, meaning you cannot use the PERC score to exclude pulmonary emobolism (PE).

Key clinical questions

Is CT pulmonary angiography the next step?

In Canada, around half of the patients tested for PE in emergency departments can have PE excluded with d-dimer testing [2]. This is a safe approach, even when the patient is suspected of having COVID [3]. The disadvantages of ordering a CT pulmonary angiogram on everyone you test includes: longer emergency department stays, department overcrowding, blocking access to the CT scanner for other sicker patients and hospital transfer in some settings. In addition, reducing CT use avoids patients being wrongly diagnosed with PE (false positives occur in 1–17% of cases) [4]. There are four different pathways for using d-dimer to exclude PE (Fig. 1). These pathways are described here in order of increasing efficiency [5] and decreasing external validation for PE exclusion. Physicians should be familiar with and use one of these approaches to exclude PE without requesting pulmonary imaging.
Fig. 1

How to exclude pulmonary embolism without CT scan

How to exclude pulmonary embolism without CT scan

Option 1: An ‘unlikely’ Wells score combined with D-dimer at the manufacturer-recommended cutoff

Developed in Canada, the Wells score is the most widely used pre-test probability score (Table 1). A total of ≤ 4 points on the Wells score is termed ‘PE unlikely’. A Wells score of ≤ 4 combined with a d-dimer below the recommended manufacturer cutoff (usually < 500 ng/ml, which equates 0.5 µg/mL reported with some assays) excludes the diagnosis of PE with high sensitivity [6]. In a recent multicentre Canadian study, 48% of all emergency patients tested for PE had a Wells score ≤ 4 and a d-dimer < 500 ng/ml [2].
Table 1

The two-level Wells score

Points
Score
 Clinical signs and symptoms of DVT3.0
 PE is the most likely diagnosis3.0
 Heart rate greater > 1001.5
 Previous PE or DVT1.5
 Surgery or bedbound 3 + days in past 4 weeks1.0
 Hemoptysis1.0
 Cancer1.0
Clinical probability
 Unlikely ≤ 4
 Likely > 4
The two-level Wells score

Option 2: An ‘unlikely’ Wells score combined with an age-adjusted D-dimer

Emergency physicians can exclude PE in patients who have a Wells score of ≤ 4 using negative age-adjusted d-dimer. Physicians may increase the d-dimer threshold between positive and negative from 500 ng/ml to (10 × patient’s age) ng/ml, for patients over the age of 50 and Wells score ≤ 4 [7]. Age-adjusted d-dimer has been prospectively validated in one European study, where only 1/1421 patients with negative age-adjusted d-dimer was diagnosed with venous thrombosis over the following 3 months [8]. Some d-dimer assays (such as HemosIL d-dimer) have a different recommended cutoff in which case this adjustment cannot be applied. Studies have used (age × 5) ng/ml when the d-dimer assay manufacturer-recommended cutoff is close to 250 ng/ml (such as HemosIL d-dimer) [9].

Option 3: The YEARS score

The YEARS score includes d-dimer testing for every patient. The YEARS score can be remembered more easily than the Wells score with only three items [10]. When there are no YEARS items, use a d-dimer threshold of 1000 ng/ml to exclude PE. When there are one or more YEARS items, use a d-dimer threshold of 500 ng/ml. One European study has externally validated a form of the YEARS score, (modified with age-adjust d-dimer in the patients with no YEARS items), where 1/648 patients negative for PE were diagnosed with venous thrombosis over the following 3 months [11]. Some d-dimer assays (such as the HemosIL d-dimer) have a different recommended cutoff and have never been studied use with the YEARS score (Table 2).
Table 2

The YEARS score

Itemsd-dimer interpretation
Clinical signs of deep vein thrombosis

If any items present, use

d-dimer < 500 ng/ml to exclude PE

If no items are present, use

d-dimer < 1000 ng/ml to exclude PE

Hemoptysis
Pulmonary embolism is the most likely diagnosis
The YEARS score If any items present, use d-dimer < 500 ng/ml to exclude PE If no items are present, use d-dimer < 1000 ng/ml to exclude PE

Option 4: An ‘unlikely’ Wells score and clinical probability-adjusted D-dimer

Clinical probability-adjusted d-dimer excludes PE with a d-dimer threshold of twice the manufacturer-recommended cutoff (1000 ng/ml for most assays) in patients with a Wells score ≤ 4 [2]. This was validated in Canadian emergency departments where 0/1325 patients with negative clinical probability-adjusted d-dimer were diagnosed with venous thrombosis within the following 3 months. Unlike age-adjusted and YEARS, there has been no external validation study assessing this approach.

Clinical pearls

Become an expert in the Wells score when you use it. Be sure to document the Wells score (or YEARS score if you are using it) every time you use d-dimer. Choose one of these four strategies and use that strategy for every patient you test for PE. Cherry picking the strategy according to your patient (e.g., using age-adjusted for older patients and YEARS for younger patients) will expose you to a greater risk of missing PE than if you simply choose one strategy and stick to it. Tell your patient that their ‘blood clot test’ (d-dimer) was negative so they know you have tested for PE.

Case resolution

You decide to use age-adjusted d-dimer because the patient’s Wells score is 1.5 (tachycardia), which places her in the ‘PE unlikely’ category. Her d-dimer result is 580 ng/ml (normal is < 500 ng/ml) and you tell the patient that her PE testing is negative. You manage her as a case of community-acquired pneumonia. Next day, her nasopharyngeal swab result is positive for COVID-19.
  11 in total

1.  Impact of the Age-Adjusted D-Dimer Cutoff to Exclude Pulmonary Embolism: A Multinational Prospective Real-Life Study (the RELAX-PE Study).

Authors:  Helia Robert-Ebadi; Philippe Robin; Olivier Hugli; Franck Verschuren; Albert Trinh-Duc; Pierre-Marie Roy; Jeannot Schmidt; Thierry Fumeaux; Guy Meyer; Daniel Hayoz; Pierre-Nicolas Carron; Pierre-Yves Salaun; François Sarasin; Olivier Rutschmann; Grégoire Le Gal; Marc Righini
Journal:  Circulation       Date:  2021-05-03       Impact factor: 29.690

2.  Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability.

Authors:  Clive Kearon; Kerstin de Wit; Sameer Parpia; Sam Schulman; Marc Afilalo; Andrew Hirsch; Frederick A Spencer; Sangita Sharma; Frédérick D'Aragon; Jean-François Deshaies; Gregoire Le Gal; Alejandro Lazo-Langner; Cynthia Wu; Lisa Rudd-Scott; Shannon M Bates; Jim A Julian
Journal:  N Engl J Med       Date:  2019-11-28       Impact factor: 91.245

3.  Small pulmonary artery defects are not reliable indicators of pulmonary embolism.

Authors:  Wallace T Miller; Lawrence A Marinari; Eduardo Barbosa; Harold I Litt; James E Schmitt; Anton Mahne; Victor Lee; Scott R Akers
Journal:  Ann Am Thorac Soc       Date:  2015-07

Review 4.  Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups : A Systematic Review and Individual-Patient Data Meta-analysis.

Authors:  Milou A M Stals; Toshihiko Takada; Noémie Kraaijpoel; Nick van Es; Harry R Büller; D Mark Courtney; Yonathan Freund; Javier Galipienzo; Grégoire Le Gal; Waleed Ghanima; Menno V Huisman; Jeffrey A Kline; Karel G M Moons; Sameer Parpia; Arnaud Perrier; Marc Righini; Helia Robert-Ebadi; Pierre-Marie Roy; Maarten van Smeden; Phil S Wells; Kerstin de Wit; Geert-Jan Geersing; Frederikus A Klok
Journal:  Ann Intern Med       Date:  2021-12-14       Impact factor: 51.598

5.  Association Between Pulmonary Embolism and COVID-19 in Emergency Department Patients Undergoing Computed Tomography Pulmonary Angiogram: The PEPCOV International Retrospective Study.

Authors:  Yonathan Freund; Marie Drogrey; Òscar Miró; Alessio Marra; Anne-Laure Féral-Pierssens; Andrea Penaloza; Barbara A Lara Hernandez; Sebastien Beaune; Judith Gorlicki; Prabakar Vaittinada Ayar; Jennifer Truchot; Barbara Pena; Alfons Aguirre; Florent Fémy; Nicolas Javaud; Anthony Chauvin; Tahar Chouihed; Emmanuel Montassier; Pierre-Géraud Claret; Céline Occelli; Mélanie Roussel; Fabien Brigant; Sami Ellouze; Pierrick Le Borgne; Said Laribi; Tabassome Simon; Olivier Lucidarme; Marine Cachanado; Ben Bloom
Journal:  Acad Emerg Med       Date:  2020-09-04       Impact factor: 3.451

6.  Can the use of an age-adjusted D-dimer cut-off value help in our diagnosis of suspected pulmonary embolism? .

Authors:  Jonathan Dutton; Martin Dachsel; Rachel Crane
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

7.  Safety of excluding acute pulmonary embolism based on an unlikely clinical probability by the Wells rule and normal D-dimer concentration: a meta-analysis.

Authors:  S M Pasha; F A Klok; J D Snoep; I C M Mos; R J Goekoop; M A Rodger; M V Huisman
Journal:  Thromb Res       Date:  2009-11-26       Impact factor: 3.944

8.  Prospective multicenter evaluation of the pulmonary embolism rule-out criteria.

Authors:  J A Kline; D M Courtney; C Kabrhel; C L Moore; H A Smithline; M C Plewa; P B Richman; B J O'Neil; K Nordenholz
Journal:  J Thromb Haemost       Date:  2008-03-03       Impact factor: 5.824

9.  Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.

Authors:  Marc Righini; Josien Van Es; Paul L Den Exter; Pierre-Marie Roy; Franck Verschuren; Alexandre Ghuysen; Olivier T Rutschmann; Olivier Sanchez; Morgan Jaffrelot; Albert Trinh-Duc; Catherine Le Gall; Farès Moustafa; Alessandra Principe; Anja A Van Houten; Marije Ten Wolde; Renée A Douma; Germa Hazelaar; Petra M G Erkens; Klaas W Van Kralingen; Marco J J H Grootenboers; Marc F Durian; Y Whitney Cheung; Guy Meyer; Henri Bounameaux; Menno V Huisman; Pieter W Kamphuisen; Grégoire Le Gal
Journal:  JAMA       Date:  2014-03-19       Impact factor: 56.272

10.  Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial.

Authors:  Yonathan Freund; Anthony Chauvin; Sonia Jimenez; Anne-Laure Philippon; Sonja Curac; Florent Fémy; Judith Gorlicki; Tahar Chouihed; Hélène Goulet; Emmanuel Montassier; Margaux Dumont; Laura Lozano Polo; Pierrick Le Borgne; Mehdi Khellaf; Donia Bouzid; Pierre-Alexis Raynal; Nizar Abdessaied; Saïd Laribi; Jeremy Guenezan; Olivier Ganansia; Ben Bloom; Oscar Miró; Marine Cachanado; Tabassome Simon
Journal:  JAMA       Date:  2021-12-07       Impact factor: 157.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.